2020 annual financial data
NovoCure 2020 Operating margin
NovoCure 2020 operating margin with verified reported values.
Direct answer
Operating margin was 6.15%.
Operating income was 30,401,000 USD and net income was 19,808,000 USD.
Operating cash flow was 99,148,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 494,366,000 USD
- Operating income
- 30,401,000 USD
- Net income
- 19,808,000 USD
- Operating cash flow
- 99,148,000 USD